Tumor necrosis factor-α inhibitor: A promising therapeutic approach for attenuating myocardial ischemia-reperfusion by antioxidant stress.
Department of Cardiology, Renmin Hospital, Wuhan University, Wuhan, Hubei, China.
Xiaoya
X
Zhou
Department of Cardiology, Sir Run Run Shaw Hospital Affiliated to Medical College of Zhejiang University, Hangzhou, China.
Xia
X
Sheng
Department of Cardiology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Mingxian
M
Chen
Department of Cardiology, Renmin Hospital, Wuhan University, Wuhan, Hubei, China.
Zhuo
Z
Wang
Department of Cardiology, Renmin Hospital, Wuhan University, Wuhan, Hubei, China. Electronic address: whuyulilei@163.com.
Lilei
L
Yu
Department of Cardiology, Renmin Hospital, Wuhan University, Wuhan, Hubei, China. Electronic address: whujianghong@163.com.
Hong
H
Jiang
D000818:Animals; D000975:Antioxidants / Q000378:metabolism* / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D017202:Myocardial Ischemia / Q000378:metabolism* / Q000628:therapy*; D015425:Myocardial Reperfusion / Q000379:methods*; D018384:Oxidative Stress / Q000187:drug effects / Q000502:physiology*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000975:Antioxidants; C439524:TNF protein, human; D014409:Tumor Necrosis Factor-alpha
Ischemia-reperfusion; Tumor necrosis factor-α inhibitor